114 related articles for article (PubMed ID: 9798411)
21. HER2/neu (c-erbB-2) gene amplification and protein expression are rare in uterine cervical neoplasia: a tissue microarray study of 814 archival specimens.
Lesnikova I; Lidang M; Hamilton-Dutoit S; Koch J
APMIS; 2009 Oct; 117(10):737-45. PubMed ID: 19775342
[TBL] [Abstract][Full Text] [Related]
22. Histogenesis of pancreatic carcinomas: a study based on 248 cases.
Chen J; Baithun SI; Ramsay MA
J Pathol; 1985 May; 146(1):65-76. PubMed ID: 4009323
[TBL] [Abstract][Full Text] [Related]
23. Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression.
Klein WM; Hruban RH; Klein-Szanto AJ; Wilentz RE
Mod Pathol; 2002 Apr; 15(4):441-7. PubMed ID: 11950919
[TBL] [Abstract][Full Text] [Related]
24. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
[TBL] [Abstract][Full Text] [Related]
25. Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma.
Cho MH; Yoon JH; Jaegal YJ; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Woo Juhng S; Min KW
Breast; 2006 Jun; 15(3):390-8. PubMed ID: 16169726
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling.
McCarthy DM; Brat DJ; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Hum Pathol; 2001 Jun; 32(6):638-42. PubMed ID: 11431719
[TBL] [Abstract][Full Text] [Related]
27. [Lesions of the pancreatic duct epithelium and histogenesis of exocrine pancreatic carcinomas].
Schulz HJ
Zentralbl Pathol; 1994 Aug; 140(3):203-10. PubMed ID: 7947629
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47.
Maitra A; Iacobuzio-Donahue C; Rahman A; Sohn TA; Argani P; Meyer R; Yeo CJ; Cameron JL; Goggins M; Kern SE; Ashfaq R; Hruban RH; Wilentz RE
Am J Clin Pathol; 2002 Jul; 118(1):52-9. PubMed ID: 12109856
[TBL] [Abstract][Full Text] [Related]
29. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
[TBL] [Abstract][Full Text] [Related]
30. Expression of interleukin-8 in human obstructive pancreatitis.
Motoo Y; Xie MJ; Mouri H; Sawabu N
JOP; 2004 May; 5(3):138-44. PubMed ID: 15138335
[TBL] [Abstract][Full Text] [Related]
31. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
Wu Y; Soslow RA; Marshall DS; Leitao M; Chen B
Gynecol Oncol; 2004 Dec; 95(3):570-5. PubMed ID: 15581965
[TBL] [Abstract][Full Text] [Related]
32. [Dysplasia and carcinoma in situ of the pancreatic duct epithelium].
Schulz HJ
Zentralbl Allg Pathol; 1988; 134(1):3-14. PubMed ID: 2833841
[TBL] [Abstract][Full Text] [Related]
33. Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma.
Moskovitz AH; Linford NJ; Brentnall TA; Bronner MP; Storer BE; Potter JD; Bell RH; Rabinovitch PS
Genes Chromosomes Cancer; 2003 Jun; 37(2):201-6. PubMed ID: 12696069
[TBL] [Abstract][Full Text] [Related]
34. HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger.
Maru D; Middleton LP; Wang S; Valero V; Sahin A
Cancer; 2005 Mar; 103(5):900-5. PubMed ID: 15643600
[TBL] [Abstract][Full Text] [Related]
35. HER-2/neu and CD117 (C-kit) overexpression in hepatocellular and pancreatic carcinoma.
Potti A; Ganti AK; Tendulkar K; Chitajallu S; Sholes K; Koch M; Kargas S
Anticancer Res; 2003; 23(3B):2671-4. PubMed ID: 12894556
[TBL] [Abstract][Full Text] [Related]
36. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer.
Cubilla AL; Fitzgerald PJ
Cancer Res; 1976 Jul; 36(7 PT 2):2690-8. PubMed ID: 1277176
[TBL] [Abstract][Full Text] [Related]
37. Proposal for the classification of epithelial atypism of pancreatic duct lesions.
Kimura W
Hepatogastroenterology; 2007; 54(79):2155-8. PubMed ID: 18251180
[TBL] [Abstract][Full Text] [Related]
38. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
Perrone G; Santini D; Vincenzi B; Zagami M; La Cesa A; Bianchi A; Altomare V; Primavera A; Battista C; Vetrani A; Tonini G; Rabitti C
Histopathology; 2005 May; 46(5):561-8. PubMed ID: 15842638
[TBL] [Abstract][Full Text] [Related]
39. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.
Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH
Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191
[TBL] [Abstract][Full Text] [Related]
40. Expression of transforming growth factor beta by small duct epithelium in chronic, cancer-associated, obstructive pancreatitis: an in situ hybridization study and review of the literature.
Fukumura Y; Suda K; Mitani K; Takase M; Kumasaka T
Pancreas; 2007 Nov; 35(4):353-7. PubMed ID: 18090242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
